Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
Health Technology Assessment
NIHR Health Technology Assessment Programme
Chronic myeloid leukaemia (CML) is a form of cancer affecting the blood, characterised by excessive proliferation of white blood cells in the bone marrow and circulating blood. In the UK, an estimated 560 new cases of CML are diagnosed each year.
Health Technology Assessment, 2012, Vol. 16, Issue 22, pp. 1 - 410
Place of publication